Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies.
about
Selective gene silencing by viral delivery of short hairpin RNAsiRNA Versus miRNA as Therapeutics for Gene SilencingBone Marrow Gene Therapy for HIV/AIDSFoamy virus vectors for HIV gene therapyA MultiSite Gateway Toolkit for Rapid Cloning of Vertebrate Expression Constructs with Diverse Research Applications.Achieving HIV-1 Control through RNA-Directed Gene RegulationCurrent prospects for RNA interference-based therapiesApplications of RNA interference high-throughput screening technology in cancer biology and virologyMicroRNAs and human retrovirusesRNA interference approaches for treatment of HIV-1 infectionReplication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replicationThe Menu of Features that Define Primary MicroRNAs and Enable De Novo Design of MicroRNA Genes.Gene targeting in primary human trophoblasts.Selection of RNAi-based inhibitors for anti-HIV gene therapyIdentification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus.Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators.Towards improved shRNA and miRNA reagents as inhibitors of HIV-1 replication.Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.Comparison of Lentiviral Packaging Mixes and Producer Cell Lines for RNAi Applications.Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.A lentiviral vector bearing a reverse intron demonstrates superior expression of both proteins and microRNAs.Silencing of HIV-1 by AgoshRNA molecules.Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.Insulators to Improve the Safety of Retroviral Vectors for HIV Gene Therapy.Association of MicroRNA Biogenesis Genes Polymorphisms with Ischemic Stroke Susceptibility and Post-Stroke Mortality.RNA virus building blocks-miRNAs not included.DROSHA Knockout Leads to Enhancement of Viral Titers for Vectors Encoding miRNA-Adapted shRNAsType III Transforming Growth Factor- Receptor RNA Interference Enhances Transforming Growth Factor 3-Induced Chondrogenesis Signaling in Human Mesenchymal Stem Cells
P2860
Q21245112-22CB2415-2658-47B3-ADAE-70A5E5CF0059Q26786876-256126E0-21AC-490F-9927-52A3E945CE78Q26801765-A2F6CD0B-5319-48B9-BB31-6D84CC1FD14AQ26859020-BFC80D2D-FCBA-4F93-AFCC-1F883EFF1C41Q27334567-75675671-D541-49C6-B679-932CAE8A6334Q28080090-B487AF28-2DAE-4FCD-9908-33A8E2DA472DQ28235733-DF373FD2-10C4-4A66-A6ED-04D63E0F8F98Q34477405-E8EFE1A5-2DA2-498B-BAAF-9831B1990B0CQ35226238-E9478A6D-EA1E-484A-BECB-AE76DDBC088AQ35652119-E0A7AB80-C0A6-47E9-9CA1-0FA93FBEA7C9Q35666657-423166B1-EC3D-4A40-92A7-D05AFBD10419Q36185497-DC4EA2E2-A564-4358-ABCF-4C9351C8B1E1Q36227415-1969560A-8C55-4EF8-B240-14B55FB33EBEQ37195531-2AC317B7-0E39-40A2-89AB-FF5440EBF6D7Q37713953-0F1B20C0-3BDD-44FA-B862-AA9A4BDE18E0Q37809086-F63AF242-7CB7-4CBA-B298-E006393F52FCQ38210324-A5FC7B38-C9C6-41CC-A9CE-BBA77A4E329AQ38267240-AE0ADE08-C3DA-4C01-984C-34A402614071Q38916998-55DCCA46-8EB7-4C9C-8C94-64AC28E86E08Q40121209-40A054B8-ED2E-4DBB-923C-1EA44E17FC6AQ40167606-F920C682-32E1-4B11-BB5B-2109B708E0B3Q40182062-5B02FFF9-EFD2-4107-8FC3-8157E8E68099Q41691498-2EBD9B87-A9A6-4414-AD79-1429955F865BQ50878341-D33E79BF-5D78-4B25-8F6F-AB61E4011EA4Q54854526-EA7CD997-7D70-4378-979D-2F2811C7D6ADQ55003673-7DD24587-BE55-42DC-B589-E88A9E52BA87Q55154293-4F12DB7D-6393-459D-BF06-AB38C0BFDE59Q57159699-EA831FA7-C32A-4FE9-BCA6-EEBB3D6D1519Q57170317-C268DFC0-2F7F-4AC5-8AF4-D30E092A4E66
P2860
Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Titers of lentiviral vectors e ...... re distinct repair strategies.
@en
type
label
Titers of lentiviral vectors e ...... re distinct repair strategies.
@en
prefLabel
Titers of lentiviral vectors e ...... re distinct repair strategies.
@en
P2093
P2860
P356
P1433
P1476
Titers of lentiviral vectors e ...... re distinct repair strategies.
@en
P2093
Ben Berkhout
Eva Ramirez de Arellano
Jan-Tinus Westerink
Monique A Vink
Olivier Ter Brake
Pavlina Konstantinova
Ying Poi Liu
P2860
P304
P356
10.1261/RNA.1887910
P407
P577
2010-05-24T00:00:00Z